ACSM2B rs73530508 polymorphism affects susceptibility to esophageal cancer by regulating indolepropionic acid levels

Background

Tryptophan metabolism is involved in esophageal carcinogenesis. However, its genetic mechanisms remain unclear. This study aimed to investigate the effect of genetic variants that encode tryptophan metabolism on susceptibility to esophageal cancer (EC) and elucidate the mechanisms underlying genetic variation in EC progression.

Methods

Age- and sex-matched cohorts of 167 patients with EC and 236 healthy controls were enrolled in this study. The concentrations of tryptophan and its metabolites were determined by self-assembled high-performance liquid chromatography-tandem mass spectrometry. High-throughput sequencing techniques were utilized to detect candidate coding genetic variants, and dominant genetic models were used to elucidate the genotypic associations.

Results

Tryptophan metabolism was significantly imbalanced in patients with EC, with elevated indolepropionic acid (IPA) levels reducing the risk of EC susceptibility. ACSM2B rs73530508 (A > G) mutation was associated with higher IPA levels in vivo (P = 0.0004, false discovery rate [FDR] = 0.0092) and significantly reduced the risk of EC susceptibility (odds ratio [OR]: 0.576, P_adj = 0.0161). Mediation effect analysis indicated that single-nucleotide polymorphism may inhibit carcinogenesis by reducing IPA metabolism and excretion with a mediation effect of 45.54%.

Conclusions

This study identifies the potential mechanism of ACSM2B rs73530508 (A > G) in esophageal carcinogenesis and its role in driving increased IPA levels, thereby suppressing the risk of development.